Villafuerte, Julieta .

HRN: 27-87-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2025
CEFTAZIDIME 1GM (VIAL)
10/01/2025
10/08/2025
IV
1g
Q8hr
CAP-MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines